Significant highlights for the AGITG

Eva and simron website

CommNETS abstract presented as oral presentation at ASCO GI.
With great pleasure we inform you that our abstract: Development of follow up recommendations for completely resected gastroenteropancreatic neuroendocrine tumours (GEP-NETS): Practice Survey of Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) in conjunction with North American Neuroendocrine Tumour Society (NANETS)- was given an oral presentation at ASCO GI. This work could not have been done without your support of CommNETS and we believe is just the tip of the iceberg! Thank you again for your belief in our concept of an international collaboration to improve care of patients with NET.
Professor Eva Segelov and Dr Simron Singh 


Best of JCO 2017 Gastrointestinal Cancer Edition
The AGITG clinical trial INTEGRATE was accepted into the best of Journal of Clinical Oncology Gastrointestinal Cancer edition. Click here for the paper: Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.

ALaCaRT selected as best of by ASCO
The ALaCart rectal surgery trial was selected by the American Society of Clinical Oncology for inclusion in Clinical Cancer Advances 2017, the society’s annual review of progress against cancer and emerging trends in the field. The study has been featured as one of the year’s major achievements internationally in clinical cancer research and care. Click here for a link to the paper originally published in Jama 2015